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Abstract
Erythrocyte hyperaggregation, a cardiovascular risk factor, is considered to be caused by an increase in plasma adhesion
proteins, particularly fibrinogen. We have recently reported a specific binding between fibrinogen and an erythrocyte
integrin receptor with a b3 or b3-like subunit. In this study we evaluate the influence of erythrocyte aging on the fibrinogen
binding. By atomic force microscopy-based force spectroscopy measurements we found that increasing erythrocyte age,
there is a decrease of the binding to fibrinogen by decreasing the frequency of its occurrence but not its force. This
observation is reinforced by zeta-potential and fluorescence spectroscopy measurements. We conclude that upon
erythrocyte aging the number of fibrinogen molecules bound to each cell decreases significantly, due to the progressive
impairment of the specific fibrinogen-erythrocyte receptor interaction. Knowing that younger erythrocytes bind more to
fibrinogen, we could presume that this population is the main contributor to the cardiovascular diseases associated with
increased fibrinogen content in blood, which could disturb the blood flow. Our data also show that the sialic acids exposed
on the erythrocyte membrane contribute for the interaction with fibrinogen, possibly by facilitating its binding to the
erythrocyte membrane receptor.
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Introduction
Human erythrocytes (red blood cells) have a in vivo life span of
approximately 120 days and are selectively removed from
circulation via phagocytosis [1]. During its life span, the
erythrocyte undergoes progressive physical and chemical changes,
such as the decrease on cell volume with cell aging. This is
presumably due to the loss of potassium and to the loss of
membrane patches by microvesiculation, resulting in an increase
on cell density [2]. Aged cells exhibit decreased deformability,
electric mobility and lower surface negative charge [3,4]. The
membrane zeta-potential (which assesses the cell surface charge),
together with the morphological and mechanical properties, are
important structural and functional parameters of erythrocytes.
They affect the deformability, and the circulation of erythrocytes
in a blood vessel. Erythrocyte aggregation is also one of the most
important factors affecting the blood flow. Increased erythrocyte
aggregation is a cardiovascular risk factor, associated with
hypertension, hypercholesterolemia and clinical conditions such
as myocardial ischemia and thromboembolic states [5]. Hadengue
et al. showed that in hypertension and hypercholesterolemia, the
increase in erythrocyte aggregation could be attributed to an
increase in the concentration of plasma fibrinogen. The prevailing
hypothesis for the mechanism of fibrinogen-induced erythrocyte
hyperaggregation was that it is caused by a nonspecific binding
mechanism [6]. However, the published data on the changes in
erythrocyte aggregation during hypertension pointed to the
possible existence of other mechanism(s) [7].
The use of nanotechnologies for medical applications raises
high expectations regarding diagnosis, drug delivery, gene
therapy and tissue engineering. There is an increasing number
of reports using AFM as a nanodiagnostic tool for patient cells.
Beside its direct relevance on the identification of the fibrinogen
receptor on erythrocytes and of a pharmacological strategy to
inhibit it, our recent work was also a demonstration of the
applicability and validation of the AFM-based force spectros-
copy technique as a highly sensitive, rapid and low operation
cost nanotool for the diagnostic and unbiased functional
evaluation of the severity of hematological diseases arising from
genetic mutations [8]. In this previous work, based on force
spectroscopy measurements using an atomic force microscope
(AFM), we reported the existence of a single-molecule
interaction between fibrinogen and an unknown receptor on
the erythrocyte membrane, with a lower but comparable affinity
relative to platelet binding (average fibrinogen-erythrocyte and -
platelet average (un)binding forces were 79 and 97 pN,
respectively). The fibrinogen-platelet binding, essential for
coagulation, depends on the platelet membrane receptor aIIbb3,
an integrin. The receptor identified by us in erythrocytes is not
as strongly influenced by calcium and eptifibatide (an aIIbb3
specific inhibitor) as the platelet receptor. However, its
inhibition by eptifibatide indicates that it is an aIIbb3-related
integrin. The results obtained for a Glanzmann thrombastenia
(a rare hereditary bleeding disease caused by aIIbb3 deficiency)
patient showed (for the first time) an impaired fibrinogen-
erythrocyte binding. Correlation with genetic sequencing data
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erythrocytes is a product of the expression of the b3 gene, found
to be mutated in this patient [8].
Knowing this, the purpose of the present study was to evaluate if
fibrinogen-erythrocyte binding is dependent on in vivo cell aging, to
assess the life span of the specific receptor and to get a further
insight on its nature. Our data indicate that increasing
erythrocytes aging, there is a significant decrease on the fibrinogen
binding, by decreasing the frequency of its occurrence but not its
binding strength. For the binding between fibrinogen and
erythrocytes to occur, a lower fibrinogen concentration is needed
on young erythrocytes than for the older ones.
Methods
Ethics Statement
Blood from healthy blood donors was obtained with their
previous written informed consent, following a protocol with the
Portuguese Blood Institute (Lisbon), approved by the Ethics
Committee of the Faculty of Medicine of the University of Lisbon.
Erythrocytes isolation
Blood was collected from adult donors into K3EDTA
anticoagulant tubes. Total erythrocyte population was separated
from the other blood components by centrifugation at 200 g for
15 min, at 20uC. After washing erythrocytes three times with
NaCl 0.9% and centrifugation at 2000 g for 5 min, packed
erythrocytes were resuspended in HEPES-buffered isotonic saline
(NaCl 133 mM, KCl 4.5 mM and HEPES 10 mM, pH 7.4) to
achieve a final concentration of 5610
9 cells/mL.
Preparation of discontinuous Percoll gradients
Different erythrocytes subpopulations were isolated using a
Percoll discontinuous gradient [9,10,11]. The gradient was built up
in five layers containing 80% (0.360 mL), 74% (2.9 mL), 70%
(2.9 mL), 66% (2.9 mL) and 60% (1.46 mL) Percoll, respectively, in
HEPES buffer containing bovine serum albumin 5.25% (w/v).
The density of the Percoll solutions varied between 1.087 and
1.098 g/mL [9]. An initial centrifugation of the gradient tube was
done at 2700 g, for 30 min, at 20uC. 1.46 mL of the isolated
erythrocyte suspension were layered on the top of the gradient
tube and a new centrifugation was done at 2700 g, for 40 min, at
20uC, with a deceleration of 3 min. Erythrocyte fractions were
collected by slowly pipetting over the liquid interface. The fraction
containing the new erythrocytes population was concentrated in
the upper layer (over Percoll 60% solution). Intermediate-aged
erythrocytes population was collected over Percoll 66% and 70%,
and the fraction containing the older senescent erythrocytes
layered over the Percoll 74% solution. All the separated fractions
were washed 3 times with HEPES-buffered isotonic saline at
2700 g, for 5 min, at 20uC.
The success of the age-dependent separation of erythrocytes
into different fractions was confirmed by the determination of the
sialic acid content on erythrocyte membranes, as previously
reported [5,9,11,12,13].
Preparation of erythrocyte integral membranes
Isolated erythrocyte integral membranes, commonly known as
erythrocyte ghosts, were prepared from the isolated erythrocytes
subpopulations. Packed erythrocytes were hemolyzed with 10
volumes of hypotonic 5P8 buffer (5 mM Na2HPO4, pH 8.0),
followed by centrifugation at 12,000 g for 20 min to collect the
membrane fraction [5]. The membrane pellets were washed with
5P8 buffer and centrifuged to remove hemoglobin from the
membranes. Membrane protein concentration was determined on
each sample with the Coomassie (Bradford) protein assay kit
(Pierce Biotechnology, Inc., Rockford, IL) using bovine serum
albumin as a standard.
Determination of sialic acid content on erythrocytes
subpopulations
Sialic acid content of isolated erythrocyte membranes was
determined by the QuantiChrom
TM Sialic Acid assay kit
(BioAssay Systems, Hayward, CA). This assay is based on an
improvement of the Warren method [14], in which sialic acid is
oxidized to formylpyruvic acid, which reacts with thiobarbituric
acid to form a pink colored product. It can be quantified at
549 nm and its absorbance is directly proportional to sialic acid
concentration in the sample. This assay allows the determination
of the free and total sialic acid concentrations on each sample,
from which the concentration of membrane-bond sialic acid is
calculated. We used a standard of N-acetylneuraminic acid
(NANA) 10 mM to construct the calibration curve.
Removal of sialic acid from erythrocytes membranes
After the separation of the total erythrocyte population from the
other blood components, washed cells were resuspended at a
concentration of 45% (v/v) in buffered saline glucose citrate
(BSGC; 1.6 mM KH2PO4, 8.6 mM Na2HPO4, 120 mM NaCl,
13.6 mM sodium citrate, 11.1 mM glucose, pH 7.3), in the
presence of 135 mUI/mL of neuraminidase (from Clostridium
perfringens, type V, Sigma, St. Louis, MO), in order to promote the
erythrocytes membrane sialic acids depletion. This suspension was
incubated at 37uC for 1 h with gentle shaking and then washed
three times with 10 volumes of BSGC buffer and centrifuged at
1500 g for 5 min. This sequence of washes of the cells is necessary
to assure that neuraminidase is excluded from the cell buffer
suspensions and subsequent experiments [5,12].
Atomic force microscopy samples preparation
For the atomic force microscopy studies, the three isolated
erythrocytes subpopulations or the neuraminidase-treated eryth-
rocytes were diluted (1/1000) with BSGC supplemented with
calcium chloride 1 mM. Erythrocytes suspensions were placed on
clean poly-L-lysine-coated glass slides and allowed to deposit, as
previously described [8].
AFM imaging
A NanoWizard II atomic force microscope (JPK Instruments,
Berlin, Germany) mounted on the top of an Axiovert 200 inverted
optical microscope (Carl Zeiss, Jena, Germany) was used for
imaging and force spectroscopy experiments. The AFM head is
equipped with a 15-mm z-range linearized piezoelectric scanner
and an infrared laser. Imaging of erythrocytes was performed in
air and in buffer, in tapping mode. Oxidized sharpened silicon tips
with a tip radius of 6 nm, resonant frequency of about 300 kHz
and spring constant of 40 N/m (ACT, Applied Nanostructures,
CA) were used for the imaging. Imaging parameters were adjusted
to minimize the force applied on the scanning of the topography of
the cells. Scanning speed was optimized to 0.3 Hz and acquisition
points were 5126512. Imaging data were analyzed with the JPK
image processing v.3 (JPK Instruments).
Fibrinogen-AFM tips functionalization
The protein-AFM tips functionalization process has been
described elsewhere [8,15,16]. Briefly, cleaned AFM silicon nitride
tips were silanized with 3-aminopropyl-triethoxysilane (APTES)
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glutaraldehyde solution 2.5% (v/v) for 20 min. Finally, the tips
were placed in a 1 mg/mL human fibrinogen solution (Sigma) for
30 min at room temperature. The functionalized fibrinogen tips
were immediately mounted on the AFM and used for the force
spectroscopy experiments.
Force spectroscopy on an atomic force microscope
Force spectroscopy measurements were performed using
fibrinogen functionalized OMCL TR-400-type silicon nitride
tips (Olympus, Tokyo, Japan), as previously described [8]. The
spring constants of the tips were calibrated, resulting in values
of 0.02160 . 0 0 5N / m .T h ea p p l i e df o r c ew a sa d j u s t e dt o1n N
before tip retraction. Data collection for each force-distance
cycle was performed at 2 mm/s, leading to a loading rate of
4 nN/s. For any given experiment, approximately 15,000 force-
distance curves were collected, analyzed and fitted to the worm-
like-chain model (WLC) [17]. Each experiment was performed
at least five times, each time on different blood samples and
with different functionalized tips. The binning sizes chosen
to build the force histograms consistently ranged between 4 and
6p N .
Labeling of human erythrocytes with di-8-ANEPPS
Once isolated by Percoll discontinuous gradient, each human
erythrocytes subpopulation was labeled with the membrane dipole
potential fluorescent probe di-8-ANEPPS (4-[2-[6-(dioctylamino)-
2-naphthalenyl]ethenyl]-1-(3-sulfopropyl)-pyridinium) [18]. Brief-
ly, a suspension at 1% hematocrit in HBSS (Hank’s Balance Salt
Solution, Invitrogen, Carlsbad, CA) buffer pH 7.4, supplemented
with 0.05% (m/V) Pluronic F-127 (Sigma) and di-8-ANEPPS
10 mM (Molecular Probes, Invitrogen) was prepared with each
erythrocyte subpopulation. The suspensions of erythrocytes with
probe were incubated in the dark, at room temperature, with
gentle agitation, for 1 h. Unbound di-8-ANEPPS was removed by
two wash cycles, with centrifugations at 1500 g, for 5 min.
Fluorescence spectroscopy measurements
The membrane probe di-8-ANEPPS assesses dipole potential
by shifting its excitation spectrum upon a perturbation on this
parameter (caused, in the present study, by the interaction of
fibrinogen with the erythrocyte membrane). The experiments
were conducted through the addition of different amounts of
soluble human fibrinogen (0–3.4 mg/mL) to the di-8-ANEPPS
labeled erythrocytes suspension (0.01% hematocrit). Differential
spectra for detecting these shifts are obtained by subtracting the
excitation spectrum of labeled cells in the presence of each of the
different fibrinogen concentrations from the spectrum in its
absence. Before subtraction the spectra were normalized to the
integrated areas to reflect only spectral shifts. The differential
spectra are waveform shaped, which amplitude directly correlates
with the peak shifting magnitude, and hence, with the dipole
potential variation.
To define the dipole potential changes due the spectral shift, a
ratio was established from the fluorescence intensities at two
wavelengths on the sides of excitation spectrum peak [19]. We
chose them by taking the corresponding wavelength values for
the minimum and the maximum of the differential spectra,
defining the ratio R for this case as the ratio between the
fluorescence intensities obtained with the excitation wavelength
at 455 nm and 525 nm, keeping the emission wavelength
constant at 670 nm. A decrease in the membrane dipole
potential leads to a red-shift in the membrane incorporated di-
8-ANEPPS and, consequently, to a decrease on this ratio [19].
The variation of R with the fibrinogen concentration was
calculated, plotted and analyzed by a single binding site model
[19], following the equation:
R
R0
~1z
Rmin
R0

Fibrinogen ½ 
Kdz Fibrinogen ½ 
ð1Þ
R values are normalized dividing by R0, corresponding to zero
fibrinogen concentration. Rmin defines the asymptotic minimum
value of R and Kd is the equilibrium dissociation constant.
All the fluorescence spectroscopy measurements were made in a
Varian Cary Eclipse (Mulgrave, Australia) fluorescence spectro-
photometer. Excitation and emission bandwidths were 5 nm and
10 nm, respectively, on all measurements.
Zeta-potential samples preparation
The samples obtained for each erythrocytes subpopulation were
set to 0.035% hematocrit (kept constant during the experiments) in
HBSS buffer pH 7.4, in the absence and presence of different
soluble human fibrinogen concentrations (0–4 mg/mL). The
suspensions were filtered using a syringe filter with 0.45 mm pore
size (Whatman, Florham Park, NJ) to remove any large scattering
particle, which would bias the light scattering measurements.
Zeta-potential measurements
Measurements were conducted on a dynamic light scattering
and zeta-potential equipment Malvern Zetasizer Nano ZS
(Malvern, UK), equipped with a He-Ne laser (l=632.8 nm).
The zeta-potential (f) of the samples were determined, at 25uC,
from the mean of 15 measurements, with 60 runs each, with an
applied potential of 30 V, in the absence and presence of different
soluble human fibrinogen concentrations, using disposable zeta
cells with platinum gold-coated electrodes (Malvern). For a recent
review on zeta-potential measurements, and their biochemical and
biophysical applications, see reference [20]. The electrophoretic
mobility obtained was used for the zeta-potential calculation
through the Smoluchowski equation [21],
f~
4pgu
e
ð2Þ
where u represents the electrophoretic mobility, g the viscosity of
the solvent and e its dielectric constant. The variation of the zeta-
potential (Df) for each sample was calculated by subtracting from
the zeta-potential value of the sample the initial value correspond-
ing to zero fibrinogen concentration. These differences can be
plotted as a function of fibrinogen concentration, and the
experimental data fitted using the equation [22,23]:
Df~
DfmaxKL Fibrinogen ½ 
1z KL Fibrinogen ½  ðÞ
ð3Þ
where Dfmax is the maximum amplitude of variation of the zeta-
potential induced by the interaction with fibrinogen, and KL
corresponds to the inverse of the value of fibrinogen concentration
at fmax/2.
Statistical analysis
Unpaired Student’s t-test was used for statistical analysis of
intergroup comparison. Differences were considered statistically
significant for p,0.05.
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AFM imaging and force spectroscopy of
fibrinogen-erythrocyte subpopulations
When performing force spectroscopy measurements (vd. Fig. 1A),
the force vs. distance curves acquired after the fibrinogen-
functionalized AFM tips contact with the erythrocytes surface
(imaged in Fig. 1B) show well-defined and measurable adhesion
forces. AFM imaging revealed the common disk shape of human
erythrocytes, with 8–10 mm of diameter and a height of
approximately 900 nm. The cells showed good adherence to
poly-L-lysine (a positively charged polymer) coated glass slides with
the experimental conditions described.
The repeated measurement of the adhesion events allows us to
create rupture-force histograms for each erythrocyte population
studied (vd. Fig. 2). Rupture force values are defined as the force
necessary to break the bond between a single fibrinogen molecule
and an erythrocyte receptor, which is characterized by the
instantaneous jumps in force observed on force-distance curves
(data not shown). Experimental data were fitted with Gaussian
curves to obtain the average rupture force for a single fibrinogen-
cell receptor binding, yielding values of 1766 pN for young
erythrocytes, 1764 pN for intermediate-aged erythrocytes and
2260.3 pN for old erythrocytes. The differences between these
values are not statistically significant. The two peaks observed on
each histogram with forces above 30 pN are probably from
multiple binding events between different fibrinogen molecules
and its cell receptor.
Each rupture-force histogram shown on Fig. 2 was adjusted to a
maximum of 750 counts on the yy-axis. We can observe from
Fig. 2 that old erythrocytes have a significant decrease on the
frequency of the binding to fibrinogen molecules, despite the fact
that the few observed adhesions have identical rupture forces to
those achieved with young or intermediate-aged erythrocytes
populations. The frequency of adhesion-rupture events achieved
for the young erythrocytes-fibrinogen system was 18.6%. For the
intermediate-aged erythrocytes-fibrinogen system this percentage
was slightly lower (13.2%) and for old erythrocytes population the
value significantly decrease (4.6%). From these adhesion events,
approximately 75% were of single rupture events and the
remaining 25% were from double or multiple steps binding
events, for the three studied erythrocytes populations.
Variation on the erythrocyte membranes sialic acid
content upon aging
As the best control of the age-dependent separation of
erythrocytes into different fractions, we determined the concen-
tration of sialic acid on each cell subpopulation. The achieved
values are of the same order as previously reported by others
[5,12]. We obtained a decrease of the sialic acid concentration on
erythrocytes membranes of 22.5% from young to old erythrocytes.
This result is in agreement with the ones obtained by other
authors, who reported a percentage of removal of sialic acids from
young to old erythrocytes of 21.2% [11] and of 15% [13]. This loss
of membrane sialic acid was also previously documented by
several other authors [3,5,12].
Neuraminidase effect on erythrocytes–fibrinogen
binding
Force spectroscopy studies were also performed with neuramin-
idase-treated erythrocytes to evaluate the effect of the presence of
sialic acids on erythrocyte membrane on the binding to fibrinogen
molecules. The achieved force rupture histogram shows an
average fibrinogen-erythrocyte binding force of 62 pN, which is
slightly lower than the obtained with the untreated erythrocytes
(79 pN for total erythrocytes population). Remarkably, the
percentage of (un)binding events decreased significantly, from
17% to 1.9%. These events can be termed (un)binding events
because, during the force spectroscopy approach/retraction cycles,
each time that there is an adhesion/binding event between a
fibrinogen molecule and a erythrocyte receptor, its binding force is
in fact measured by the changes on the AFM tip deflection at the
retraction curve when bond break occurs.
Fibrinogen-erythrocyte binding evaluation by
fluorescence spectroscopy measurements
The interaction of fibrinogen with the different erythrocytes
subpopulations was assessed by fluorescence spectroscopy, using
the dipole potential membrane probe di-8-ANEPPS [18,19,24].
This probe indirectly allows the quantitative assessment of the
binding of fibrinogen to erythrocytes, based on the changes on the
cell membrane potential arising from the fibrinogen binding. The
differential fluorescence excitation spectra obtained for two
fibrinogen concentrations, using labeled total erythrocytes, are
Figure 1. Force Spectroscopy technique at an Atomic Force Microscope. (A) Schematic representation of the erythrocytes deposited on a
poly-L-lysine-coated glass slide and an AFM tip chemically functionalized with fibrinogen molecule(s). The arrows represent the approach and retract
cycles during the force spectroscopy measurements. When approaching the tip to the sample, the fibrinogen molecule may contact with cell
receptor(s) and the binding between them can occur. By retracting the tip away from the sample, the binding force necessary to break this bond, at
the single-molecule level, can be measured. (B) Air tapping-mode AFM images of typical circular, biconcave human erythrocytes, from healthy
donors, deposited on poly-L-lysine coated glass slides (height 3D image).
doi:10.1371/journal.pone.0018167.g001
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curve obtained at low wavelengths indicates a decrease in the
dipole potential of the membrane upon fibrinogen binding. A
detailed study of the interaction was obtained by plotting the
normalized parameter R as a function of fibrinogen concentration
(Fig. 4). As fibrinogen concentration increases, the ratio Rnorm
diminishes in a fibrinogen concentration-dependent manner. The
fitting of the data to a single binding site model yields Kd values of
(5862)610
27 M and (6063)610
27 M for young and old
erythrocytes, respectively. This variation is not statistically
significant.
Fibrinogen-erythrocyte binding evaluation by
zeta-potential measurements
The zeta-potential values obtained for young and old
erythrocytes in the absence of fibrinogen clearly show the
difference between both subpopulations (vd. Fig. 5A). In the
absence of fibrinogen, young erythrocytes have significantly lower
(p,0.05) zeta-potential values (214.8 mV) when compared to the
old erythrocytes subpopulation (211.3 mV). In the presence of
fibrinogen, there is a substantial increase of the zeta-potential for
both subpopulations, converging to a similar threshold (vd. Fig. 5A).
The electrophoretic mobility and zeta-potential values can be
related with the affinity of the interaction. To measure the
extension of the fibrinogen binding to the two erythrocyte
subpopulations, the Df values were calculated and fitted to
Eq. 3 (Fig. 5B). The extension of the fibrinogen-young erythrocytes
cells interaction obtained, Dfmax, is (7.661.8) mV, significantly
higher than the value of (4.761.1) mV, obtained for old
erythrocytes.
Discussion
In this study, we evaluated if the binding between fibrinogen
and erythrocytes is dependent on the in vivo process of cell aging.
Using force spectroscopy, at an atomic force microscope, zeta-
potential and fluorescence spectroscopy measurements, we could
conclude that with the increase of the age of erythrocytes, a
significant decrease of the binding to fibrinogen occurs.
We recently reported the existence of a specific binding between
fibrinogen and an erythrocyte receptor with a (un)binding force
lower but comparable to the determined for the fibrinogen-platelet
binding [8]. We also showed that this interaction is mediated by an
Figure 2. Rupture-force histograms of fibrinogen-erythrocytes
interactions. Rupture-force histograms from about 15,000 force
measurements for each of the interactions between fibrinogen and
young erythrocytes (blue), intermediate-aged erythrocytes (green) and
old erythrocytes (red) subpopulations. All measurements were done
with an applied force of 1 nN, pulling speed of 2 mm/s and loading rate
of 4 nN/s. Gaussian peaks adjustment curves are shown in light green.
doi:10.1371/journal.pone.0018167.g002
Figure 3. Differential spectra of di-8-ANEPPS-labeled erythro-
cytes. Differential spectra of di-8-ANEPPS-labeled total erythrocytes in
the presence of 1 mg/mL (black) and 3 mg/mL (orange) of fibrinogen
(after subtraction of the spectrum obtained in the absence of
fibrinogen). The shape of the spectra shows a spectral shift to the
red, indicative of a decrease in membrane dipole potential. The
corresponding wavelength values for minimum and the maximum of
the differential spectra defined the ratio R I455nm/I525nm was used for
further experiments.
doi:10.1371/journal.pone.0018167.g003
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expressed by the same gene as platelet’s b3 unit. Now, also by force
spectroscopy technique, and after the isolation of erythrocyte
subpopulations with different ages, the (un)binding force values
obtained were similar for the three subpopulations tested. It should
be mentioned that the values obtained were lower than those
achieved with the total erythrocyte population (79 pN [8]). We
hypothesize that this discrepancy could be explained by the
presence of bovine serum albumin on the Percoll gradient cells
isolation isotonic buffer. Bovine serum albumin is known to have
capacity of binding to lipids so it could bind to the erythrocyte
phospholipid membrane, coating part of the cell surface and make
the fibrinogen receptors on erythrocyte membrane less accessible
for the binding to fibrinogen [25,26]. Therefore, force results
obtained after Percoll isolation should only be correctly compared
quantitatively with those obtained in the same medium.
Force spectroscopy reveals to be a good biophysical method to
determine the interaction forces between fibrinogen and human
blood cells. At variance with other methodologies, the process of
cell isolation is not an issue with this technique because the
measurements are conducted at the single-cell level. After isolating
the erythrocytes, the fibrinogen interactions are measured on the
top of a single erythrocyte at a time, while it can be optically
imaged in real-time, assuring that it is not another type of blood
cell. The possibility of the AFM-based force spectroscopy
measurements with erythrocytes being an artifact due to platelet
membrane fragments bound onto erythrocytes surface can be
ruled out based on the following evidences: i) considering the
binding/unbinding frequencies obtained on this study and on our
previous results [8], for this hypothesis to be possible it would be
necessary that at least 80% of the membranes of all erythrocytes
would be covered by ‘‘plastered’’ fragments; ii) it would also be
necessary that the platelet fragments-erythrocytes binding would
be considerably stronger than the fibrinogen-receptor interaction,
in order for the fragments not to be pulled-off from the
erythrocytes membrane upon AFM tip retraction; and, iii) our
previous kinetics, thermodynamics, calcium-dependence and
inhibition by eptifibatide results [8] show that the fibrinogen-
receptor in erythrocytes is different from the receptor in platelets.
On the AFM imaging of the different erythrocytes populations,
we did not find considerable morphological changes, which
obviously do not exclude possible changes on other cell properties.
As assessed by force spectroscopy, there were also no significant
changes on the rupture force value of the three studied
erythrocytes populations. However, we obtained a dramatic
decrease on the percentage of binding events with erythrocyte
aging. There are several reports studying the altered properties of
erythrocytes during the senescence process [2,3,27]. During
erythrocytes aging, there is an increase on the cell density,
decreases on deformability and electric mobility, and a lower
negative membrane charge [2]. Activities of some cytoplasmatic
enzymes also decline during erythrocyte aging. An alteration in the
lipid composition (phospholipids, unesterefied cholesterol and
glycolipids) and loss of asymmetry between the inner and outer
leaflets of the lipid bilayer is associated with erythrocytes
senescence. The interaction between phosphatidylserine and the
cytoskeleton component spectrin triggers the accumulation of
large amounts of phosphatidylserine and phosphatidylethanol-
amine on the outer leaflet erythrocyte membrane [3]. Other
changes in membrane components and organization are also
observed on aged erythrocytes, including changes on carbohy-
Figure 4. Fibrinogen affinity to different erythrocytes subpop-
ulations. The dependence of the ratios obtained for young and old
erythrocytes for different fibrinogen concentrations were analyzed by a
single binding site model (solid line) in order to quantify the
dissociation constants. Plotted values correspond to ratio values
normalized by the value corresponding to the absence of fibrinogen.
doi:10.1371/journal.pone.0018167.g004
Figure 5. Zeta-potential of erythrocytes populations. (A) Zeta-
potential values of isolated young and old erythrocytes in the presence
of different fibrinogen concentrations. (B) Variation of zeta-potential for
the same erythrocyte subpopulations. Dfmax young=(7.661.8) mV;
Dfmax old=(4.761.1) mV. Statistically significant differences (p,0.05)
were found between the two erythrocytes subpopulations.
doi:10.1371/journal.pone.0018167.g005
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lectin-like receptors), proteins (e.g., modification of band 3 protein,
a major transmembrane glycoprotein in erythrocyte, either by
proteolytic cleavage or aggregation) and decrease on the activities
of several enzymes (including enzymes of the glycolytic and
pentose shunt pathways, involved in cell thiol metabolism and
protection against oxidative damage, enzymes involved in the
catabolism of nucleotides, and others) [2,3].
In spite of the success on the assessment of the fibrinogen-
erythrocyte interaction through the changes in the dipole potential
of the labeled membranes, we did not find a statistically significant
difference between the fibrinogen dissociation constants obtained
for young and old erythrocytes. However, the values obtained
indicate a higher binding of fibrinogen to younger erythrocytes,
pointing to the same conclusion as those obtained by force
spectroscopy. Several studies have been developed to clarify the
behavior of fibrinogen in the presence of ligands of physiological
importance [28,29]. A previous work indicated that b-estradiol
binds to human fibrinogen with a Kd=1.55610
27 M [28]. By
comparing the dissociation constant obtained in our experiments
with those obtained in previous studies, we can say that it
corresponds to a high affinity binding site [28,29].
Isolated fractions of old erythrocytes move more slower in the
electric field than young erythrocytes of the same blood sample
[30,31]. In order to analyze the variation of the electrostatic forces
for erythrocytes subpopulations in the absence and presence of
fibrinogen, the interaction was monitored by zeta-potential
measurements. In agreement with the results obtained AFM-
based force spectroscopy measurements (and with the fluorescence
data, if they would be statistically-significant), two different
behaviors were registered by zeta-potential measurements for
young and old erythrocytes, clearly showing the difference
between both subpopulations (vd. Fig. 5A). Furthermore, our data
show that the zeta-potential, or the related electrophoretic
mobility, can be used to determine the extension of the interaction
between two particles, by calculating the value of Dfmax. The
obtained results clearly reflect the behavior of both cell types in the
presence of different fibrinogen concentrations. The extension of
fibrinogen-young erythrocytes cells interaction obtained is esti-
mated by Dfmax=(7.661.8) mV, a value significantly higher than
the obtained for old erythrocytes, Dfmax=(4.761.1) mV.
In the absence of fibrinogen, young erythrocytes have
significantly lower values of zeta-potential (214.8 mV) when
compare to the old erythrocytes subpopulation (211.3 mV), in
agreement with the reported by other authors [27]. The 24%
decreased on the surface charge from young to old cells may be
explained by the fact that sialic acid, the principal source of
membrane negative charge on erythrocytes, is lost during cell
aging (vd. results of sialic acid concentrations on different aging
erythrocyte subpopulations), reducing the total surface negative
charge [27,32]. By increasing fibrinogen concentration to 4 mg/
mL, the zeta-potential threshold attained is almost identical for
both sample types, showing that the charge in the erythrocyte
surface is partially neutralized by the presence of fibrinogen. These
results clearly reinforce the hypothesis that the electrostatics forces
contribute for the first step of fibrinogen-erythrocyte interaction
[29], facilitating the binding to the fibrinogen membrane receptor.
However, this convergence for the same charge value, away from
complete neutralization, despite the difference in the initial
membrane charge, suggests that the key parameter for the
interaction is not the global membrane charge, but the presence
of a specific charged membrane component, that would be
progressively lost upon cell aging. This observation prompted us to
evaluate if the membrane sialic acids would be this charged
component, by testing the effect of the neuraminidase-promoted
sialic acids depletion. The force spectroscopy data obtained after
the treatment with neuraminidase indicate that sialic acids can be
this specific charged membrane component, being progressively
lost during erythrocyte aging.
The observed decrease of membrane sialic acids content may be
associated with an alteration of glycophorin A, a major
sialoglycoprotein of human erythrocyte membrane, which may
contribute to erythrocytes transient aggregation in circulation
[5,33]. Removal of sialic acid residues of the saccharide chains of
glycophorin A, during erythrocyte aging, results in the exposure of
a new antigen, recognized by immunoglobins G, leading to a
normal process of elimination of aged cells by macrophages [5]. As
we found that removal of sialic acids decreases the number of
fibrinogen-erythrocyte receptor binding events, without signifi-
cantly affecting the (un)binding forces of each interaction at the
single-molecule level, we can presume that the existence of
erythrocyte membrane-bounded sialic acids facilitate the binding
of the cell to fibrinogen molecules, by increasing the probability of
the contact between fibrinogen and its erythrocyte membrane
receptor.
Using a fluorescence spectroscopy methodology, we did not find
a significant difference between the fibrinogen specific affinities to
the different erythrocytes population. On the other hand,
significant changes in rupture force and in the fibrinogen-
dependent zeta-potential variation were found during erythrocyte
aging. As we have pointed out before [8], some methods are able
to show that the fibrinogen-erythrocyte interaction exists, but fail
on further characterizing it. This is probably results from the
transient character of the fibrinogen-erythrocyte interaction,
which can be properly studied mainly by force spectroscopy and
also by zeta-potential measurements, but limits the details that can
be assessed by fluorescent membrane dipole potential probes. This
transient interaction cannot lead to clot formation, but is able to
increase erythrocyte aggregation, increasing cardiovascular risk.
We have previously shown that, in some situations, the lifetime of
the fibrinogen-erythrocyte bond is only 0.04% of the lifetime of the
fibrinogen-platelet binding [8], pointing out why only some
methodologies can properly follow subtle variations on the binding
of fibrinogen to erythrocytes.
The present study indicates that the fibrinogen-erythrocyte
receptor binding can be lost, masked or progressively turned to
non-functional with the in vivo erythrocyte senescence process.
Additionally, our data points out to the role of the sialic acid
residues, present in several erythrocyte membrane components, as
promoters of the interaction of fibrinogen with its receptor.
Therefore, the decrease on the fibrinogen-erythrocyte interaction
during cell aging can be largely associated to the progressive
depletion of sialic acids on older erythrocytes. Knowing that
younger erythrocytes bind more to fibrinogen, we could presume
that this population is the main responsible for some cardiovas-
cular diseases associated with an increase on the fibrinogen
content in blood, which could disturb its normal flow.
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